Table 4 Association of Secondary outcomes with LDL-C ≤ 70 vs. 70 < LDL-C < 100
Outcomes | Crude model | PS matched | |||||
|---|---|---|---|---|---|---|---|
No (LDL ≤ 70/ 70 < LDL ≤ 100) | HR, OR | P value | No (LDL ≤ 70/ 70 < LDL ≤ 100) | HR, OR | P value | ||
Non-fatal CVEs | 493 (11.8%)/ 681 (11.7%) | 1.026 (0.913–1.152) * | 0.872 | 465 (12.0%)/ 465 (12.0%) | 1.032 (0.891–1.195) | 0.674 | |
ACS | 367 (8.8%)/ 547 (9.4%) | 0.950 (0.832–1.085) * | 0.231 | 349 (9.0%)/ 364 (9.4%) | 0.862 (0.660–1.125) | 0.275 | |
CVA | 126 (3.0%)/ 133 (2.3%) | 1.343 (1.053–1.714) * | 0.003 | 116 (3.0%)/ 101 (2.6%) | 1.145 (1.012–1.297) | 0.033 | |
Revascularization | 0 / 1 | - | - | - | - | - | |
In hospital mortality | 63 (1.5%)/ 77 (1.3%) | 1.147 (0.820–1.603) # | 0.112 | 57 (1.5%)/ 46 (1.2%) | 1.234 (0.894–1.856) | 0.261 | |
Intubation time (hour) | 14.701 ± 9.012/ 14.626 ± 10.213 | - | 0.818 | 14.55 ± 9.012/ 14.50 ± 10.318 | - | 0.965 | |
Length of ICU admission (hour) | 50.691 ± 12.093/ 51.054 ± 12.563 | - | 0.943 | 51.234 ± 12.123/ 51.454 ± 12.163 | - | 0.832 | |